These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33654433)

  • 1. Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer.
    Li WC; Wang Z; Gao J; Zhou H; Li J; Zhu XX
    Cancer Manag Res; 2021; 13():1887-1896. PubMed ID: 33654433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features and Prognostic Factor of Thoracic Postoperative Oligo-Recurrence of Non-Small-Cell Lung Cancer.
    Yuan Q; Wang W; Zhang Q; Wang Y; Chi C; Xu C
    Cancer Manag Res; 2020; 12():1397-1403. PubMed ID: 32158271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients.
    Aoki S; Yamashita H; Takahashi W; Nawa K; Ota T; Imae T; Ozaki S; Nozawa Y; Nakajima J; Sato M; Anraku M; Nitadori J; Karasaki T; Abe O; Nakagawa K
    Oncol Lett; 2020 Apr; 19(4):2695-2704. PubMed ID: 32218820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a retrospective analysis.
    Lin Q; Zhou N; Zhu X; Lin J; Fang J; Gu F; Sun X; Wang Y
    J Radiat Res; 2022 Mar; 63(2):272-280. PubMed ID: 34958672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review.
    Cozzi S; Alì E; Bardoscia L; Najafi M; Botti A; Blandino G; Giaccherini L; Ruggieri MP; Augugliaro M; Iori F; Sardaro A; Iotti C; Ciammella P
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study.
    Piao MN; Xie J; Jin MM; Ma XT; Dou Z; Wang JP; Li JL
    Transl Lung Cancer Res; 2024 Aug; 13(8):1950-1963. PubMed ID: 39263027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response criteria in solid tumors (PERCIST/RECIST) and SUV
    Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
    Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.
    Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y
    J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Body Radiation Therapy for Salvage Treatment of Recurrent Non-Small Cell Lung Cancer.
    Kowalchuk RO; Waters MR; Richardson KM; Spencer KM; Larner JM; Kersh CR
    Pract Radiat Oncol; 2020; 10(6):e475-e484. PubMed ID: 32454175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy.
    Milano MT; Kong FS; Movsas B
    Transl Lung Cancer Res; 2019 Feb; 8(1):78-87. PubMed ID: 30788237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing efficacy and safety of stereotactic body radiation therapy for oligometastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) wild type.
    Hu X; Li H; Liu H; Liu Z; Xia T; Zhang J; Wang Y
    Transl Cancer Res; 2021 Jan; 10(1):184-194. PubMed ID: 35116250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for hilar or mediastinal lymph node metastases after definitive treatment with stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer.
    Manabe Y; Shibamoto Y; Baba F; Murata R; Yanagi T; Hashizume C; Iwata H; Kosaki K; Miyakawa A; Murai T; Yano M
    Pract Radiat Oncol; 2012; 2(4):e137-e143. PubMed ID: 24674177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of stereotactic body radiation therapy versus surgery for multiple primary lung cancers after prior radical resection: A multicenter retrospective study.
    Dong B; Chen R; Zhu X; Wu Q; Jin J; Wang W; Zhu Y; Jiang H; Bi N; Wang X; Xu X; Xu Y; Chen M
    Clin Transl Radiat Oncol; 2023 May; 40():100601. PubMed ID: 36936471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity.
    Miszczyk M; Kraszkiewicz M; Moll M; Kaminiów K; Sobel S; Dolla Ł; Wojcieszek P; Rajwa P; Yanagisawa T; Nowicka Z; Shariat SF; Goldner G; Miszczyk L; Majewski W
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: Patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09).
    Lee TH; Shin H; Ahn YC; Kang MK; Song C; Kim WC; Moon SH; Kim JH; Cho J; Park HJ; Lee HK; Kim BH; Kim HJ
    Radiother Oncol; 2023 Jun; 183():109572. PubMed ID: 36822359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers.
    Horne ZD; Richman AH; Dohopolski MJ; Clump DA; Burton SA; Heron DE
    Lung Cancer; 2018 Jan; 115():1-4. PubMed ID: 29290248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.